Rankings
▼
Calendar
XLO Q1 2020 Earnings — Xilio Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
XLO
Xilio Therapeutics, Inc.
$29M
Q1 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$131,000
Operating Income
-$8M
Net Income
-$8M
EPS (Diluted)
$-19.83
Cash Flow
Operating Cash Flow
-$4,907
Free Cash Flow
-$5,697
Stock-Based Comp.
$96
← FY 2020
All Quarters
Q2 2020 →
